EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The feasibility of mindfulness‐based relapse prevention for adults with substance use disorders (illicit drugs) in a Chinese population: A pilot randomized controlled trial

Ka Tsun Ting iD, Ivan Chun Him Leung, Dicken Cheong Chun Chan, Ken On Tai Yu, Wai Kwong Tang iD, Fu Chan, Alan Ka Lam Tang, Helen Shuk Wah Ma, Benjamin Hon Kei Yip, Daisy Dexing Zhang, Sarah Bowen, Samuel Yeung Shan Wong iD

Addiction · 2026-09 · 121 (9) · 2433-2449

DOI: 10.1111/add.70441 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Addiction, online erschienen am 30.04.2026. Verfasst von Ka Tsun Ting und 11 weiteren Autor:innen. Beteiligte Einrichtung: JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Mindfulness, Substance-Related Disorders, Secondary Prevention. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beat Drugs Fund, Narcotics Division, Security Bureau, Hong Kong SAR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims Mindfulness‐based relapse prevention (MBRP) has been shown to be beneficial to individuals with substance use disorder (SUD) in the West. The current pilot study aimed at testing the feasibility of MBRP in a Chinese population.

Design

This pilot study adopted a design of randomized controlled trial comparing MBRP with treatment‐as‐usual group (TAU).

Setting

Participants were recruited from residential detox centers, community addiction counseling centers and substance abuse clinics specialized addiction treatment clinics in Hong Kong.

Participants

A total of 81 adults (85.2% male) with SUD (illicit drugs only) were recruited.

Interventions

The intervention group participants ( n = 41) attended a 1‐hour orientation session followed by 2‐hour weekly MBRP sessions for 8 weeks, delivered by a qualified MBRP teacher. The TAU group participants ( n = 40) continued their service received from their referral agency. (After completion of all study assessments they were offered the same 8‐week MBRP course.)

Measurements

Feasibility was measured by attendance, course satisfaction and retention rate. Participants' change in substance use and other related outcomes were captured by self‐reported drug use, urine drug tests and a list of psychometric scales at baseline, immediately after MBRP and 3‐ and 6‐month follow‐up.

Findings

The MBRP course satisfaction was high, and the attendance (57.4%) and retention rates (63.4%–85.4%) were comparable to previous trials. No statistically significant differences were observed between the MBRP and TAU groups for any outcomes, including craving, depression, anxiety, mindfulness and health‐related quality of life; however, improvement trends were noticed in the MBRP group in self‐efficacy in managing high‐risk situations at post intervention, as well as in addiction severity and psychological flexibility at the 6‐month follow‐up.

Conclusions

Mindfulness‐based relapse prevention was shown to be feasible for substance use disorder treatment in a Chinese population. In this small study there was only limited evidence of abstinence efficacy, and no evidence of a benefit on other secondary outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MindfulnessSubstance-Related DisordersSecondary PreventionHumansPilot ProjectsFemaleFeasibility StudiesAdultMaleHong KongMiddle AgedEast Asian People

Stichwörter der Autor:innen

ChineseMBRPillicit drugmindfulnessmindfulness‐based relapse preventionsubstance use disorder

Autor:innen und Institutionen

  • JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
  • Thomas Jing Centre for Mindfulness Research and Training, The Chinese University of Hong Kong, Hong Kong, China.
  • Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
  • Department of Psychiatry, North District Hospital, Hospital Authority, Hong Kong, China.
  • Department of Psychiatry, Shatin Hospital, Hospital Authority, Hong Kong, China.
  • Hong Kong Centre for Mindfulness, Hong Kong, China.

ORCID-Profile: Ka Tsun Ting, Wai Kwong Tang, Samuel Yeung Shan Wong

Förderung

  • Beat Drugs Fund, Narcotics Division, Security Bureau, Hong Kong SAR

Zitieren

APA

Ting, K. T., Leung, I. C. H., Chan, D. C. C., Yu, K. O. T., Tang, W. K., Chan, F., Tang, A. K. L., Ma, H. S. W., Yip, B. H. K., Zhang, D. D., Bowen, S., & Wong, S. Y. S. (2026). The feasibility of mindfulness‐based relapse prevention for adults with substance use disorders (illicit drugs) in a Chinese population: A pilot randomized controlled trial. Addiction, 121(9), 2433-2449. https://doi.org/10.1111/add.70441

Vancouver

Ting KT, Leung ICH, Chan DCC, Yu KOT, Tang WK, Chan F, et al. The feasibility of mindfulness‐based relapse prevention for adults with substance use disorders (illicit drugs) in a Chinese population: A pilot randomized controlled trial. Addiction. 2026;121(9):2433-2449. doi:10.1111/add.70441

BibTeX
@article{Ting2026,
  author = {Ting, Ka Tsun and Leung, Ivan Chun Him and Chan, Dicken Cheong Chun and Yu, Ken On Tai and Tang, Wai Kwong and Chan, Fu and Tang, Alan Ka Lam and Ma, Helen Shuk Wah and Yip, Benjamin Hon Kei and Zhang, Daisy Dexing and Bowen, Sarah and Wong, Samuel Yeung Shan},
  title = {The feasibility of mindfulness‐based relapse prevention for adults with substance use disorders (illicit drugs) in a Chinese population: A pilot randomized controlled trial},
  journal = {Addiction},
  year = {2026},
  volume = {121},
  number = {9},
  pages = {2433--2449},
  doi = {10.1111/add.70441}
}
Kostenlos starten →